🚀 A Major Milestone!
We have officially submitted 510(k) application to the U.S. FDA .
This marks an important step in our mission to make fertility treatment more accessible, affordable, and effective for couples around the world.
#MedTech#FDA#Innovation#boostfertility
More than 1,000 injections. Five IVF cycles. Two miscarriages.
Stories like this remind us why innovation in fertility care matters—not just to improve success rates, but to reduce the burden on patients.
💜 Every step counts.
https://t.co/NHvKklI3Lu
0.78 babies born per woman this year and probably 0.65 next year in South Korea. Yes, this is worst case scenario, but still, it's a very scary trend. https://t.co/fuGfjPjlYa
A powerful series of articles in the Economist highlighting major issues with IVF. Key quote: "Less discussed are the problems of IVF. Most courses of treatment fail." Here's the full article: https://t.co/ASFgxsufht
Femtech is a trillion dollar business. Key quote: investment in femtech could lead to innovative solutions for women’s health challenges that have long been considered inconsequential or too difficult to solve. That's what we are doing at our123Baby. https://t.co/m6ligcQTmR
What is the correlation between sperm quality and miscarriages? It is becoming more and more evident that the DNA quality of sperm significantly influences the outcome of fertility treatments.
Referenced study:
https://t.co/yzvkhZA9rT
Music: Yehezkel Raz - The Wanderer
What is the DNA Fragmentation Index (DFI)? In this short video we explain the maybe most important sperm parameter for fertility evaluation.
Music: I am good by Alex MakeMusic
Current Fertility Treatments Disproportionally Burden Women - Watch our short video to learn more.
Further read: Male Infertility is a Women’s Health Issue—Research and Clinical Evaluation of Male Infertility Is Needed
https://t.co/Zv57XIndK0